Neogen Chemicals Ltd (NEOGEN) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by Neogen Chemicals Ltd on NSE and BSE, with an AI summary of each filing.
Intimation of Analyst/Investor Meeting to be held on November 17, 2026.
Intimation · 04 Nov 2026, 8:32 pm
Neogen Chemicals to Attend Avendus Spark Investor Conference on 17th Nov'26 Neogen Chemicals Limited announced that its management will participate in the Avendus Spark INDX: Building India’s Innovation Economy Annual Investor Conference on 17th Nov'26 at 9:00 a.m. IST at Grand Hyatt, Mumbai. The interaction will involve a mix of 1x1 and group meetings focusing on the company's business overview, financial performance, and future outlook. The company confirmed that no unpublished price sensitive information (UPSI) will be shared during these interactions.
Monitoring agency report for the quarter ended September 30, 2026 i.r.o. QIP of Rs. 600 crores.
Others (Uncategorized) · 03 Nov 2026, 9:38 pm
Neogen Chemicals Reports Zero Deviation in ₹600 Crore QIP Utilization CRISIL Ratings confirmed no deviation in Neogen Chemicals' utilization of its ₹600.00 crore QIP proceeds for the quarter ended 30th Sep'26. The company utilized ₹248.88 crore, including ₹163.07 crore for working capital, ₹63.71 crore for general corporate purposes (mainly capex of ₹46.98 crore), ₹18.52 crore for issue expenses, and ₹3.57 crore for loan repayments. The remaining unutilized ₹351.12 crore is deployed in bank fixed deposits (₹278.00 crore) and the monitoring bank account balance (₹73.12 crore).
Earnings call recording Q2 H1 FY 2027
Audio / Video · 03 Nov 2026, 12:12 am
Neogen Chemicals Releases Q2 FY27 Investor Conference Call Audio Recording Neogen Chemicals Limited has disclosed that the audio recording of its Analysts and Investors Conference Call, conducted on 2nd Nov'26 at 5:00 p.m. regarding its Q2 FY27 performance, is now accessible on the company's official website. This disclosure adheres to Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015.
Earnings Presentation for the quarter and half year ended 30-09-2026
Investor Presentation · 02 Nov 2026, 4:57 am
Neogen Chemicals Delivers Strong Q2 FY27 Financial Growth Amid Battery Materials Scaling Neogen Chemicals reported a 42% YoY increase in consolidated revenue to INR 296 crore for Q2 FY27, driven by a surge in Battery Chemicals revenue to INR 37 crore. Consolidated EBITDA grew 51% YoY to INR 45.3 crore with a 15.3% margin, while PAT rose 144% YoY to INR 8.2 crore. The company raised INR 600 crore via QIP to de-leverage debt and approved an INR 45 crore expansion of its Organolithium facility to 600 MTPA. CRISIL revised its rating outlook to 'CRISIL A-/Stable'.
Press Release for the Quarter and half year ended 30-09-2026.
Press Release · 02 Nov 2026, 4:56 am
Neogen Chemicals Delivers Strong Q2 FY27 Results Driven by Battery Chemicals Ramp-Up Neogen Chemicals reported Q2 FY27 consolidated revenue of INR 296 crore, up 42% YoY, supported by INR 37 crore from battery chemicals via Neogen Ionics. Consolidated EBITDA grew 51% YoY to INR 45 crore, while PAT surged 144% YoY to INR 8 crore, despite elevated input costs and ongoing CAPEX depreciation. The company successfully raised INR 600 crore through an oversubscribed QIP to deleverage its balance sheet. Additionally, the board approved an INR 45 crore expansion of its organolithium facility at Patancheru, doubling capacity to 600 MTPA.
Neogen Chemicals Limited has submitted to the Exchange, the financial results for the quarter and half year ended September 30, 2026, and other matters approved by the Board.
Outcome · 01 Nov 2026, 2:02 am
Statement of Deviation and Variation w.r.t. QIP
Others (Uncategorized) · 01 Nov 2026, 1:57 am
Neogen Chemicals Reports Zero Deviation in QIP Proceeds Utilization for Sep'26 Quarter Neogen Chemicals reported zero deviation in the utilization of funds raised via its ₹600 crore Qualified Institutional Placement (QIP) completed on 16th Sep'26. For the quarter ended 30th Sep'26, the company deployed ₹230.35 crore across key objectives against an allocated net proceeds base of ₹580 crore. Utilization included ₹163.07 crore for long-term working capital (₹175 crore allocated), ₹63.71 crore for general corporate purposes (₹140 crore allocated), and ₹3.57 crore for debt repayment (₹265 crore allocated). Additionally, ₹18.52 crore was spent on issue-related expenses.
Security cover certificate as on September 30, 2026
Others (Uncategorized) · 01 Nov 2026, 1:55 am
Neogen Chemicals Submits 2.63x Security Cover Certificate for Listed NCDs Neogen Chemicals submitted its statutory auditor-certified Security Cover Certificate as of 30th Sep'26 for 20,000 listed Non-Convertible Debentures (NCDs) aggregating Rs. 200 cr (ISIN: INE136S07013). Statutory auditor Chandabhoy & Jassoobhoy confirmed full compliance with all debenture covenants and SEBI regulations. Based on standalone financial records, total assets allocated under pari-passu charge stood at Rs. 1,955.51 cr against total pari-passu debt of Rs. 752.15 cr (including listed NCD debt of Rs. 198.06 cr), delivering a robust asset security cover ratio of 2.63x on book value.
Outcome of Board meeting held on Saturday, October 31, 2026
Outcome · 01 Nov 2026, 1:50 am
Neogen Chemicals Limited has informed the Exchange about Material Related Party Transactions to be entered, subject to approval of the shareholders of the Company.
Outcome · 01 Nov 2026, 1:49 am
Neogen Chemicals Limited has informed the Exchange about outcome of Board Meeting held on October 31, 2026.
Outcome · 01 Nov 2026, 1:38 am
Outcome of Board meeting held on Saturday, October 31, 2026
Outcome · 01 Nov 2026, 1:36 am
Neogen Chemicals Limited has informed the Exchange about expanding the existing Organo-Lithium chemicals manufacturing facility from 300 MT/PA of active to 600 MT/PA of active at Patancheru, Telangana.
Outcome · 01 Nov 2026, 1:34 am
Unaudited Financial Results (Standalone and Consolidated) for the quarter and half year ended September 30, 2026
Financial Result · 01 Nov 2026, 1:33 am
Neogen Chemicals Limited has informed the Exchange about Giving guarantees/indemnity/ becoming a surety for third party
Outcome · 01 Nov 2026, 1:31 am
Neogen Chemicals Limited has submitted to the Exchange, the financial results for the quarter and half year ended September 30, 2026, and other matters approved by the Board.
Outcome · 01 Nov 2026, 1:23 am
1) Unaudited Financial Results of the Company for the quarter and half year ended 30-09-2026 2) Statement of Deviation/Variation in utilization of funds for the quarter ended 30-09-2026 ....
Outcome · 01 Nov 2026, 1:23 am
Neogen Chemicals Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Crore) ■ Revenue: 296 (+41.8% YoY | +18.2% QoQ) ■ EBITDA: 45.3 (+51.3% YoY | -6.0% QoQ) ■ EBITDA Margin (%): 15.3 (+95 bps YoY | -396 bps QoQ) ■ PAT: 8.2 (+144.2% YoY | -51.9% QoQ) ■ EPS (INR): 2.96 (+131.3% YoY | -52.9% QoQ)
Update on Insurance Claim
Others (Uncategorized) · 30 Oct 2026, 7:12 pm
Neogen Chemicals Accepts Additional Rs. 152 Crore Fire Insurance Settlement Neogen Chemicals has accepted an additional interim insurance claim of Rs. 152.00 crore for its Dahej SEZ fire incident, taking total on-account claims received/receivable and scrap sales to Rs. 316.49 crore. Further settlements covering asset reinstatement and business interruption losses will occur in subsequent stages. Construction of the replacement Multi-Purpose Plant (MPP3) facility is partly completed, with trial runs underway. To mitigate earnings disruption, critical specialty product manufacturing has been shifted to other sites alongside ongoing expansion at its Patancheru facility.
Update on Insurance Claim
Others (Uncategorized) · 30 Oct 2026, 7:10 pm
Neogen Chemicals Agrees Additional ₹152 Crore Fire Insurance Settlement Neogen Chemicals has accepted an additional ₹152.00 crore insurance claim settlement regarding the Dahej SEZ plant fire, taking total on-account claims received/receivable and scrap sales to ₹316.49 crore. Further settlement stages will assess business interruption and asset reinstatement. The company recognized consolidated damages of ₹362.90 crore against insurance receivables of ₹348.82 crore. To mitigate earnings disruption while MPP3 reconstruction progresses—where trial runs have begun in completed sections—Neogen has shifted critical specialty production to alternative sites and is advancing Patancheru plant expansions.
Neogen Chemicals Limited has informed the Exchange about Board Meeting to be held on 31-Oct-2026 to consider and approve the Quarterly Unaudited Financial results of the Company for the period ended September 2026 and Other business.
Intimation · 31 Oct 2026, 5:30 am
Intimation of earnings conference call scheduled to be held on Monday, November 2, 2026 at 5:00 p.m. for analysts/investors
Intimation · 02 Nov 2026, 5:00 pm
Neogen Chemicals Schedules Q2FY27 Earnings Conference Call Neogen Chemicals Limited has scheduled its Q2FY27 earnings conference call on Monday, 2nd Nov'26, at 5:00 PM IST. Senior management will discuss financial performance followed by an interactive Q&A session. As a key manufacturer of bromine, lithium chemicals, and battery materials, Neogen operates four facilities across Maharashtra, Gujarat, and Telangana, and commercially supplies lithium-ion battery electrolytes via its subsidiary, Neogen Ionics Limited. Dial-in details include universal access (+91 22 6280 1141 / 7115 8042) alongside international toll-free options for key global regions.
To consider and approve the financial results for the period ended September 30, 2026 and approve early voluntary full redemption of 20000 listed NCDs of a face value of Rs. 100000 each.
Intimation · 31 Oct 2026, 5:30 am
Neogen Chemicals Limited has informed the Exchange about Board Meeting to be held on 31-Oct-2026 to consider and approve the Quarterly Unaudited Financial results of the Company for the period ended September 2026 and Other business.
Intimation · 31 Oct 2026, 5:30 am
Neogen Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/10/2026 ,inter alia, to consider and approve 1) Approval of unaudited standalone ....
Intimation · 31 Oct 2026, 5:30 am
Neogen Chemicals Board to Consider Q2 Results and INR 200 Crore NCD Redemption Neogen Chemicals Limited announced a Board of Directors meeting scheduled for 31st Oct'26 to consider and approve un-audited standalone and consolidated financial results for the quarter and half-year ended 30th Sep'26. Additionally, the board will evaluate and consider a proposal for the voluntary full redemption of 20,000 secured, listed, rated Non-Convertible Debentures (NCDs) aggregating to INR 200 crore, originally allotted on 12th Aug'25. The company's trading window remains closed until 48 hours post the declaration of the financial results.
Disclosure pertaining to approval by the Board of Neogen Morita New Materials Limited (NML) for issuance of equity shares of NML on Preferential Issue basis.
Others (Uncategorized) · 27 Sept 2026, 1:19 am
Neogen Chemicals Unit Approves ₹76.80 Cr Preferential Issue to Morita Investment Neogen Morita New Materials Limited (NML), a step-down subsidiary of Neogen Chemicals Limited, approved the preferential issuance of 7,20,000 equity shares (face value ₹10) to Morita Investment Limited (MIL) on 26th Sep'26. Priced at ₹1,066.66 per share (including ₹1,056.66 premium), the transaction aggregates to ₹76.80 crore. Following the allotment, MIL, a subsidiary of Morita Chemicals Industries, will hold a 9.09% stake in NML. The transaction executes under the joint venture agreement dated 31st Aug'25, subject to shareholder and regulatory approvals.